Domainex specialises in recombinant protein solutions. Domainex's patent pending Combinatorial Domain Hunting (CDH) technology enables a wide range of hitherto intractable recombinant projects to be progressed as abundant and stable purifiable proteins for downstream needs as diverse as drug and vaccine development, including structural biology and cell biology.

The Domainex in-house research programme is taking forward the next generation in drug and vaccine targets, while providing a cost-effective and reliable bespoke service in CDH to global biotech and pharma.